Sorrento Therapeutics Inc (SRNEQ) Return on Assets ROA from the second quarter of 2023 to second quarter of 2022 and for the year 2023, Average High and Low, Fundamental Ratios from Jun 30 2023 to Jun 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Sorrento Therapeutics Inc   (SRNEQ)


Sorrento Therapeutics Inc 's ROA from the second quarter of 2023 to the second quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Sorrento Therapeutics Inc 's ROA in the second quarter of 2023?
Sorrento Therapeutics Inc recorded a cumulative net loss of $-354 million during 12 months ending in the second quarter of 2023, resulting in a negative return on assets (ROA) of -83.13%.

However, within the Healthcare sector Sorrento Therapeutics Inc achieved the highest return on assets. While the total ranking for ROA unchanged, relative to the first quarter of 2023 at no. .

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter
Y / Y Total Assets Change -26.23 % -51.13 % -36.47 % 33.52 % -26.42 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -354 -465 -351 -496 -525
Return On Assets (TTM) -83.13 % -100.7 % -62.58 % -80.43 % -90.08 %
SRNEQ's Total Ranking # # # # #
Total Assets (TTM) in million 404 378 389 532 547
Seq. Total Assets Change 6.92 % -2.77 % -27 % -2.79 % -29.17 %
Seq. Net Income Change - - - - -

SRNEQ's 5 Years Annual ROA >> Back to SRNEQ Management Effectiveness >> Compare SRNEQ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Assets Statistics
High Average Low
0 %
0 %
0 %
 





Financial Statements
Sorrento Therapeutics Inc 's Assets $ 404 million SRNEQ's Balance sheet
Sorrento Therapeutics Inc 's Income $ -109 million Quarterly SRNEQ's Income Statement
SRNEQ's Income by Division See SRNEQ's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change -36.47 % 23.36 % -11.1 % -10.65 % 44.59 %
Total Assets in million 389 612 496 558 624
Y / Y Net Income Change - - - - -
Net Income in million -578 -429 -314 -363 -213
Annual Return On Assets -148.71 % -70.17 % -63.42 % -65.1 % -34.05 %

SRNEQ's 5 Years Annual ROA >> Back to SRNEQ Management Effectiveness >> Compare SRNEQ ROA to its Competitors



More Return On Assets Ratios
SRNEQ's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SRNEQ's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SRNEQ's Competitors
Subscribers only: Roa for Sorrento Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for SRNEQ's Customers

You may also want to know
SRNEQ's Roi SRNEQ's Inventory Turnover Ratio SRNEQ's Growth Rates SRNEQ's Dividend Comparisons
SRNEQ's Profitability Ratios SRNEQ's Asset Turnover Ratio SRNEQ's Dividend Growth
SRNEQ's Roe SRNEQ's Valuation Ratios SRNEQ's Financial Strength Ratios SRNEQ's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2023, within Healthcare Sector ROA

Date modified: 2026-09-08T15:11:02+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.